- Home
- ARL vs CMPX Comparison
ARL vs CMPX Comparison
Compare ARL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- CMPX
- Stock Information
- Founded
- ARL 1999
- CMPX 2014
- Country
- ARL United States
- CMPX United States
- Employees
- ARL N/A
- CMPX N/A
- Industry
- ARL Building operators
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- CMPX Health Care
- Exchange
- ARL Nasdaq
- CMPX Nasdaq
- Market Cap
- ARL 251.2M
- CMPX 214.6M
- IPO Year
- ARL N/A
- CMPX N/A
- Fundamental
- Price
- ARL $13.91
- CMPX $2.92
- Analyst Decision
- ARL
- CMPX Strong Buy
- Analyst Count
- ARL 0
- CMPX 6
- Target Price
- ARL N/A
- CMPX $12.50
- AVG Volume (30 Days)
- ARL 4.3K
- CMPX 1.3M
- Earning Date
- ARL 03-21-2025
- CMPX 03-20-2025
- Dividend Yield
- ARL N/A
- CMPX N/A
- EPS Growth
- ARL N/A
- CMPX N/A
- EPS
- ARL N/A
- CMPX N/A
- Revenue
- ARL $51,029,000.00
- CMPX $850,000.00
- Revenue This Year
- ARL N/A
- CMPX N/A
- Revenue Next Year
- ARL N/A
- CMPX $613.39
- P/E Ratio
- ARL N/A
- CMPX N/A
- Revenue Growth
- ARL 0.87
- CMPX N/A
- 52 Week Low
- ARL $12.51
- CMPX $0.77
- 52 Week High
- ARL $22.77
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- ARL 47.20
- CMPX 48.30
- Support Level
- ARL $12.66
- CMPX $3.14
- Resistance Level
- ARL $13.40
- CMPX $3.85
- Average True Range (ATR)
- ARL 0.57
- CMPX 0.33
- MACD
- ARL -0.02
- CMPX -0.11
- Stochastic Oscillator
- ARL 58.06
- CMPX 5.68
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.